Seven Leadership Lessons from The Medtech Conference 2022
The Medtech Conference 2022 featured plenary speakers and panelists who shared enough wisdom to fill books. Read on for leadership lessons from the conference.
AdvaMed’s Medtech POV blog features all the latest developments, perspectives, and resources by and for the medical technology community.
The Medtech Conference 2022 featured plenary speakers and panelists who shared enough wisdom to fill books. Read on for leadership lessons from the conference.
In a RealClearHealth op-ed, AdvaMed president and CEO Scott Whitaker outlines how the recently enacted medical device user fee agreement will help the FDA and medical technology innovators.
Congress overwhelmingly approved the fifth Medical Device User Fee Amendment (MDUFA) agreement, helping to ensure new medical technology receives a more efficient FDA review to reach patients sooner if approved.
October is Breast Cancer Awareness Month and a good time to remember the importance of diagnostic screenings in saving lives.
Brought to you by AdvaMed, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
CEO and surgeon Dr. Lishan Aklog speaks about the tremendous value of medical technology, the sharp disparities patients face, and the importance of policymaking to ease those disparities.
AdvaMed’s Deputy General Counsel and Senior, VP of Legal, Pat Fogarty, joined Jack Kalavritinos, host of Capital Forum, and Jonathan Turner, Global Head of Compliance, Privacy and Governance, Zoll Medical,…
Mick Farrell, CEO of ResMed, joined Scott Whitaker on the Medtech POV podcast to explain what motivates him to serve patients and his community.
In recent years, private investors have been subject to increased government enforcement scrutiny under the False Claims Act. Given investors’ vital role in medtech, AdvaMed developed tools and resources to…
If you have media inquiries, please contact:
Cody Uhing, Director, Communications & Media Relations, 202-316-1423
Frans van Houten, CEO of Royal Philips, explains the potentially dire consequences of unchecked chip shortages for monitoring unborn babies, treating sudden cardiac arrest patients, assessing the vital signs of…
Join over 400 medical technology companies as a member of one of the most effective trade associations in Washington, D.C.